Conditions: Idiopathic Thrombocytopenic Purpura Purpura, Thrombocytopenic, Idiopathic
Keywords: eltrombopag thrombopoietin receptor agonist ITP blood platelet
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 19
Healthy volunteers: no

Brief summary:
An open-label, dose-adjustment extension study to evaluate the safety and efficacy of eltrombopag for treatment of subjects with ITP who have previously been enrolled in the eltrombopag trial TRA108109 (NCT00540423).

Detailed description:

Arms:
arm 1: Eltrombopag oral tablets once daily

Interventions: intervention 1: Eltrombopag oral tablets
Intervention descriptions: intervention 1: Eltrombopag oral tablets once daily

Protocol document: